Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024
17 January 2024 - 8:01AM
Business Wire
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication
management solutions and adherence tools for healthcare systems and
pharmacies, will release its financial results for the fourth
quarter and full year 2023, before market open on Thursday,
February 8, 2024. The Company will host a conference call and
webcast to discuss its financial results at 8:30 a.m. ET that same
day.
All interested parties are invited to listen to the live call
and presentation by dialing (888) 550-5424 in the U.S. or (646)
960-0819 in international locations. The Conference ID is 9581556.
A link to the live and archived webcast will also be available on
the Investor Relations section of Omnicell’s website at
https://ir.omnicell.com/events-and-presentations/.
About Omnicell
Since 1992, Omnicell has been committed to transforming pharmacy
care through outcomes-centric innovation designed to optimize
clinical and business outcomes across all settings of care. Through
a comprehensive portfolio of robotics, smart devices, software, and
expert services, Omnicell solutions are helping healthcare
facilities worldwide to uncover cost savings, improve labor
efficiency, establish new revenue streams, enhance supply chain
control, support compliance, and move closer to the
industry-defined vision of the Autonomous Pharmacy. To learn more,
visit omnicell.com.
OMNICELL and the Omnicell logo are registered trademarks of
Omnicell, Inc. or one of its subsidiaries.
OMCL-E
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240116200665/en/
Kathleen Nemeth Senior Vice President, Investor Relations
ir@omnicell.com
Omnicell (NASDAQ:OMCL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Omnicell (NASDAQ:OMCL)
Historical Stock Chart
From Sep 2023 to Sep 2024